Research And Select A Respiratory Disease That Has A Signifi

Researchandselecta Respiratory Disease That Has A Significant Impact O

Research and select a respiratory disease that has a significant impact on society and the health care industry. Write a 700- to 1,050-word paper. Your paper should: Describe the respiratory disease you selected. Describe the treatments used to treat the disease. Consider holistic and traditional treatments. Identify the disease type (primary, secondary, or tertiary) for the respiratory disease. Describe why the respiratory disease is classified as the disease type you identified. Describe what impact the respiratory disease you selected has on society as it relates to the business of health care and the use of resources. Cite at least 2 reputable references.

Paper For Above instruction

The respiratory disease I have selected for this paper is asthma, a prevalent chronic respiratory condition that significantly impacts society and the healthcare industry worldwide. Asthma is characterized by inflammation and narrowing of the airways, leading to episodes of wheezing, breathlessness, chest tightness, and coughing. Its persistent nature and potential severity make it a significant public health concern, particularly given its impact on vulnerable populations including children, the elderly, and low-income communities.

Asthma affects approximately 262 million people globally, according to the World Health Organization (WHO, 2017). Environmental factors such as air pollution, allergens, and respiratory infections can trigger asthma exacerbations, thereby increasing emergency healthcare visits and hospitalizations. The disease's burden extends beyond individual suffering, influencing economic productivity due to missed work and school days. In the United States alone, asthma is responsible for over 1.8 million visits to emergency departments annually, alongside substantial healthcare costs (Centers for Disease Control and Prevention [CDC], 2019). As such, asthma's societal impact encompasses both health and economic dimensions, straining healthcare resources and prompting ongoing research into better management strategies.

The treatment landscape for asthma includes a combination of pharmacological, holistic, and lifestyle interventions. Conventional treatments primarily involve inhaled corticosteroids (ICS), bronchodilators such as beta-agonists, leukotriene modifiers, and biologic therapies for severe cases. These treatments aim to control airway inflammation, prevent exacerbations, and improve airway function. In recent years, holistic approaches have gained recognition for their complementary role, including breathing exercises like Buteyko breathing, acupuncture, yoga, and dietary modifications aimed at reducing inflammation (Bousquet et al., 2020). Patient education on trigger avoidance and adherence to medication regimens remains critical in managing the disease effectively.

Asthma is primarily classified as a secondary disease because it develops as a consequence of underlying respiratory inflammation or allergic reactions triggered by environmental factors or genetic predisposition. Unlike primary diseases, which originate directly within the organ system involved, asthma results from a complex interplay of immune responses that cause airway hyperresponsiveness. Tertiary classifications generally refer to complications or advanced disease states, which may develop if asthma is poorly managed, leading to airway remodeling and chronic respiratory impairment. However, in its initial stages or as a managed chronic condition, asthma is best categorized as secondary because it arises from a systemic inflammatory process affecting the airways.

The societal impact of asthma on healthcare and resource utilization is considerable. Its prevalence necessitates ongoing medical management, frequent use of emergency care, and hospitalization during severe exacerbations. Healthcare resources are also allocated to preventive programs, public health campaigns, and research for better treatments. Moreover, the economic burden encompasses direct costs like physician visits, medications, hospital stays, and indirect costs such as lost productivity due to illness or caregiving responsibilities. The increasing prevalence of asthma, coupled with disparities in access to healthcare, amplifies these challenges, emphasizing the need for efficient resource allocation and innovative management strategies within the healthcare system (Akinbami et al., 2019).

References

• Akinbami, L. J., Moorman, J. E., Bailey, C., et al. (2019). Trends in Asthma Prevalence, Health Care Use, and Mortality in the United States, 2001–2010. NCHS Data Brief, No. 94, 1–8.
• Bousquet, J., F අවහා, S., et al. (2020). Holistic approaches in asthma management. European Respiratory Journal, 55(6), 200056.
• Centers for Disease Control and Prevention (CDC). (2019). Most Recent National Asthma Data. Retrieved from https://www.cdc.gov/asthma/most_recent_data.htm
• World Health Organization (WHO). (2017). Asthma. Retrieved from https://www.who.int/news-room/fact-sheets/detail/asthma